Correlation Between Bausch Health and Soleno Therapeutics

Can any of the company-specific risk be diversified away by investing in both Bausch Health and Soleno Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bausch Health and Soleno Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bausch Health Companies and Soleno Therapeutics, you can compare the effects of market volatilities on Bausch Health and Soleno Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bausch Health with a short position of Soleno Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bausch Health and Soleno Therapeutics.

Diversification Opportunities for Bausch Health and Soleno Therapeutics

0.64

Correlation Coefficient

Bausch Health  Soleno Therapeutics

Poor diversification

The 3 months correlation between Bausch and Soleno is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding Bausch Health Companies and Soleno Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Soleno Therapeutics and Bausch Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bausch Health Companies are associated (or correlated) with Soleno Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Soleno Therapeutics has no effect on the direction of Bausch Health i.e., Bausch Health and Soleno Therapeutics go up and down completely randomly.

Pair Corralation between Bausch Health and Soleno Therapeutics

Considering the 90-day investment horizon Bausch Health Companies is expected to under-perform the Soleno Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bausch Health Companies is 1.46 times less risky than Soleno Therapeutics. The stock trades about -0.23 of its potential returns per unit of risk. The Soleno Therapeutics is currently generating about -0.09 of returns per unit of risk over similar time horizon. If you would invest  5,614  in Soleno Therapeutics on September 3, 2024 and sell it today you would lose (343.00) from holding Soleno Therapeutics or give up 6.11% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Bausch Health Companies  vs.  Soleno Therapeutics

Bausch Health Companies

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical indicators, Bausch Health exhibited solid returns over the last few months and may actually be approaching a breakup point.

Soleno Therapeutics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Soleno Therapeutics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Soleno Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bausch Health and Soleno Therapeutics

The main advantage of trading using opposite Bausch Health and Soleno Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bausch Health position performs unexpectedly, Soleno Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Soleno Therapeutics will offset losses from the drop in Soleno Therapeutics' long position.

The idea behind Bausch Health Companies and Soleno Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.